{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:35:57Z","timestamp":1793270157205,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012834","name":"Gifu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K07433"],"award-info":[{"award-number":["JP23K07433"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bbrep.2026.102811","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:38:10Z","timestamp":1790131090000},"page":"102811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Limited impact of NLRP3 inflammasome deficiency on diet-induced metabolic dysfunction-associated steatohepatitis in mice"],"prefix":"10.1016","volume":"48","author":[{"given":"Daisuke","family":"Taguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2471-090X","authenticated-orcid":false,"given":"Yohei","family":"Shirakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Minowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3291-0274","authenticated-orcid":false,"given":"Hiroyuki","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2026.102811_bib1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"European association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrep.2026.102811_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrep.2026.102811_bib3","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/hepr.13947","article-title":"Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: a large-scale multicenter retrospective study","volume":"53","author":"Fujii","year":"2023","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bbrep.2026.102811_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.13110","article-title":"Usefulness of health checkup-based indices in identifying metabolic dysfunction-associated steatotic liver disease","volume":"8","author":"Miwa","year":"2024","journal-title":"JGH Open"},{"key":"10.1016\/j.bbrep.2026.102811_bib5","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/apt.17995","article-title":"Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: a multicenter study in Japan","volume":"59","author":"Tsutsumi","year":"2024","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbrep.2026.102811_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/apt.18015","article-title":"Long-term clinical outcomes in steatotic liver disease and incidence of liver-related events, cardiovascular events and all-cause mortality","volume":"60","author":"Tamaki","year":"2024","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbrep.2026.102811_bib7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00535-021-01796-x","article-title":"Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020","volume":"56","author":"Tokushige","year":"2021","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbrep.2026.102811_bib8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/hepr.13688","article-title":"Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020","volume":"51","author":"Tokushige","year":"2021","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bbrep.2026.102811_bib9","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.clnu.2022.06.037","article-title":"The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis","volume":"41","author":"Haigh","year":"2022","journal-title":"Clin Nutr"},{"key":"10.1016\/j.bbrep.2026.102811_bib10","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1038\/s41598-024-52797-8","article-title":"Usefulness of a questionnaire for assessing the relationship between eating behavior and steatotic liver disease among Japanese male young adults","volume":"14","author":"Miwa","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2026.102811_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186423","article-title":"Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations","volume":"135","author":"Schnabl","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrep.2026.102811_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115861","article-title":"NLRP3 inflammasome in hepatic diseases: a pharmacological target","volume":"217","author":"Ramos-Tovar","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102811_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.24341","article-title":"Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells","volume":"54","author":"Csak","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrep.2026.102811_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbrep.2026.102811_bib15","article-title":"Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD","volume":"7","author":"Pierantonelli","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2026.102811_bib16","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41374-021-00535-3","article-title":"NLRP3 deficiency did not attenuate NASH development under high fat calorie diet plus high fructose and glucose in drinking water","volume":"101","author":"Zhu","year":"2021","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrep.2026.102811_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100330","article-title":"Genetic deletion or pharmacologic inhibition of the Nlrp3 inflammasome did not ameliorate experimental NASH","volume":"64","author":"Ioannou","year":"2023","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrep.2026.102811_bib18","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrep.2026.102811_bib19","article-title":"NLRP3 deficiency reprograms hepatic glucose metabolism but fails to ameliorate hepatic inflammation and fibrosis in the MCD model","volume":"13","author":"Zou","year":"2026","journal-title":"Genes Dis."},{"key":"10.1016\/j.bbrep.2026.102811_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","author":"Matsumoto","year":"2013","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.bbrep.2026.102811_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115922","article-title":"Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology","volume":"9","author":"Liang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2026.102811_bib22","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/jgh.16171","article-title":"Skeletal muscle atrophy is exacerbated by steatotic and fibrotic liver-derived TNF-\u03b1 in senescence-accelerated mice","volume":"38","author":"Shirakami","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrep.2026.102811_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251942","article-title":"Inhibitory effects of a selective prostaglandin E2 receptor antagonist RQ-15986 on inflammation-related colon tumorigenesis in APC-mutant rats","volume":"16","author":"Shirakami","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2026.102811_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12876-014-0212-z","article-title":"Inhibitory effects of astaxanthin on azoxymethane-induced colonic preneoplastic lesions in C57\/BL\/KsJ-db\/db mice","volume":"14","author":"Kochi","year":"2014","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.bbrep.2026.102811_bib25","first-page":"834","article-title":"Liver acid sphingomyelinase inhibits growth of metastatic colon cancer","volume":"123","author":"Osawa","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrep.2026.102811_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123294","article-title":"ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model","volume":"5","author":"Schuster-Gaul","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbrep.2026.102811_bib27","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.32320","article-title":"NOD-like receptor protein 3 activation causes spontaneous inflammation and fibrosis that mimics human NASH","volume":"76","author":"Calcagno","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrep.2026.102811_bib28","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jcmgh.2022.06.007","article-title":"Cell-specific deletion of NLRP3 inflammasome identifies myeloid cells as key drivers of liver inflammation and fibrosis in Murine steatohepatitis","volume":"14","author":"Kaufmann","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrep.2026.102811_bib29","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s10753-017-0628-z","article-title":"NLRP3 deletion inhibits the non-alcoholic steatohepatitis development and inflammation in kupffer cells induced by palmitic acid","volume":"40","author":"Cai","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.bbrep.2026.102811_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100924","article-title":"An overview of the non-canonical inflammasome","volume":"76","author":"Downs","year":"2020","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.bbrep.2026.102811_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114472","article-title":"Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis","volume":"161","author":"Shan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrep.2026.102811_bib32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","article-title":"Inflammasome activation and function in liver disease","volume":"12","author":"Szabo","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrep.2026.102811_bib33","article-title":"Inflammasomes and fibrosis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826003717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826003717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:02:06Z","timestamp":1793268126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580826003717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S2405580826003717"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102811","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limited impact of NLRP3 inflammasome deficiency on diet-induced metabolic dysfunction-associated steatohepatitis in mice","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102811"}}